← EPO Patent Bulletin

BISPECIFIC ANTIBODIES AGAINST CD3 AND CD20

Search Report EP4678661A3 Kind: A3 Mar 18, 2026

Applicants

Genmab A/S

Inventors

ENGELBERTS, Patrick, BREIJ, Esther, C. W., RADEMAKER, Rik, ALTINTAS, Isil, SATIJN, David, VERPLOEGEN, Sandra, RADERSMA, Riemke Van Dijkhuizen, VAN DEN BRINK, Edward, N., SCHUURMAN, Janine, PARREN, Paul

Abstract

Bispecific antibodies directed to CD3 and CD20 and uses of such bispecific antibodies, in particular use thereof in the treatment of diseases in which specific targeting and T cell-mediated killing of cells that express CD20 is desired.

IPC Classifications

A61K 39/00 20060101AFI20260210BHEP A61P 35/00 20060101ALI20260210BHEP C07K 16/28 20060101ALI20260210BHEP C07K 16/30 20060101ALI20260210BHEP C07K 16/46 20060101ALI20260210BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR